Literature DB >> 16199887

SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation.

Gillian M Tannahill1, Joanne Elliott, Anna C Barry, Linda Hibbert, Nicolas A Cacalano, James A Johnston.   

Abstract

Cytokine responses can be regulated by a family of proteins termed suppressors of cytokine signaling (SOCS) which can inhibit the JAK/STAT pathway in a classical negative-feedback manner. While the SOCS are thought to target signaling intermediates for degradation, relatively little is known about how their turnover is regulated. Unlike other SOCS family members, we find that SOCS2 can enhance interleukin-2 (IL-2)- and IL-3-induced STAT phosphorylation following and potentiate proliferation in response to cytokine stimulation. As a clear mechanism for these effects, we demonstrate that expression of SOCS2 results in marked proteasome-dependent reduction of SOCS3 and SOCS1 protein expression. Furthermore, we provide evidence that this degradation is dependent on the presence of an intact SOCS box and that the loss of SOCS3 is enhanced by coexpression of elongin B/C. This suggests that SOCS2 can bind to SOCS3 and elongin B/C to form an E3 ligase complex resulting in the degradation of SOCS3. Therefore, SOCS2 can enhance cytokine responses by accelerating proteasome-dependent turnover of SOCS3, suggesting a mechanism for the gigantism observed in SOCS2 transgenic mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199887      PMCID: PMC1265772          DOI: 10.1128/MCB.25.20.9115-9126.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

Review 1.  Signaling by type I and II cytokine receptors: ten years after.

Authors:  M Gadina; D Hilton; J A Johnston; A Morinobu; A Lighvani; Y J Zhou; R Visconti; J J O'Shea
Journal:  Curr Opin Immunol       Date:  2001-06       Impact factor: 7.486

Review 2.  Negative regulation of cytokine signaling pathways.

Authors:  H Yasukawa; A Sasaki; A Yoshimura
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  Twenty proteins containing a C-terminal SOCS box form five structural classes.

Authors:  D J Hilton; R T Richardson; W S Alexander; E M Viney; T A Willson; N S Sprigg; R Starr; S E Nicholson; D Metcalf; N A Nicola
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

4.  The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2.

Authors:  T Kamura; M N Conrad; Q Yan; R C Conaway; J W Conaway
Journal:  Genes Dev       Date:  1999-11-15       Impact factor: 11.361

5.  Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain.

Authors:  A Hoeflich; M Wu; S Mohan; J Föll; R Wanke; T Froehlich; G J Arnold; H Lahm; H J Kolb; E Wolf
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

6.  The inducible elongin A elongation activation domain: structure, function and interaction with the elongin BC complex.

Authors:  T Aso; D Haque; R J Barstead; R C Conaway; J W Conaway
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

Review 7.  Transgenic models of growth hormone action.

Authors:  J J Kopchick; L L Bellush; K T Coschigano
Journal:  Annu Rev Nutr       Date:  1999       Impact factor: 11.848

8.  Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase.

Authors:  T Kamura; D Burian; Q Yan; S L Schmidt; W S Lane; E Querido; P E Branton; A Shilatifard; R C Conaway; J W Conaway
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

9.  Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation.

Authors:  Serge Haan; Paul Ferguson; Ulrike Sommer; Meena Hiremath; Daniel W McVicar; Peter C Heinrich; James A Johnston; Nicholas A Cacalano
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

Review 10.  Cytokine receptor signalling.

Authors:  J N Ihle
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

View more
  56 in total

Review 1.  Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins.

Authors:  Camille A Knosp; James A Johnston
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

2.  Effect of suppressor of cytokine signaling 2 (SOCS2) on fat metabolism induced by growth hormone (GH) in porcine primary adipocyte.

Authors:  Hai Li Yang; Chan Sun; Chao Sun; Ren Li Qi
Journal:  Mol Biol Rep       Date:  2012-06-23       Impact factor: 2.316

Review 3.  Erythropoietin receptor response circuits.

Authors:  Don M Wojchowski; Pradeep Sathyanarayana; Arvind Dev
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

4.  SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases.

Authors:  Joanne Elliott; Yvonne Suessmuth; Linda M Scott; Krystyna Nahlik; Mary Frances McMullin; Stefan N Constantinescu; Anthony R Green; James A Johnston
Journal:  Haematologica       Date:  2009-02-19       Impact factor: 9.941

Review 5.  Dendritic cells and parasites: from recognition and activation to immune response instruction.

Authors:  Claudia Cristina Motran; Laura Fernanda Ambrosio; Ximena Volpini; Daiana Pamela Celias; Laura Cervi
Journal:  Semin Immunopathol       Date:  2016-09-01       Impact factor: 9.623

6.  High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

Authors:  George S Laszlo; Rhonda E Ries; Chelsea J Gudgeon; Kimberly H Harrington; Todd A Alonzo; Robert B Gerbing; Susana C Raimondi; Betsy A Hirsch; Alan S Gamis; Soheil Meshinchi; Roland B Walter
Journal:  Leuk Lymphoma       Date:  2014-03-24

7.  Leptin signaling: A key pathway in immune responses.

Authors:  Claudio Procaccini; Elaine V Lourenco; Giuseppe Matarese; Antonio La Cava
Journal:  Curr Signal Transduct Ther       Date:  2009-01-01

8.  The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.

Authors:  Meiling Cui; Ji Sun; Jianjing Hou; Tao Fang; Xin Wang; Chao Ge; Fangyu Zhao; Taoyang Chen; Haiyang Xie; Ying Cui; Ming Yao; Jinjun Li; Hong Li
Journal:  Tumour Biol       Date:  2016-07-28

9.  Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis.

Authors:  Xinyu Qiu; Jianyong Zheng; Xiaodong Guo; Xingchun Gao; Hui Liu; Yanyang Tu; Yongsheng Zhang
Journal:  Mol Cell Biochem       Date:  2013-03-11       Impact factor: 3.396

10.  SOCS2 influences LPS induced human monocyte-derived dendritic cell maturation.

Authors:  Jin Hu; Ola Winqvist; Amilcar Flores-Morales; Ann-Charlotte Wikström; Gunnar Norstedt
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.